Gå direkt till huvudinnehållet

Trombocyttransfusioner

Senast uppdaterad: Publicerad:
Sakkunnig:
  1. Stroncek DF, Rebulla P. Platelet transfusions. Lancet 2007; 370: 427-38. PubMed  
  2. Freireich EJ. Supportive care for patients with blood disorders. Br J Haematol 2000; 111: 68-77. PubMed  
  3. Sullivan MT and Wallace EL. Blood collection and transfusion in the United States in 1999. Transfusion 2005; 45: 141-8. PubMed  
  4. Sweeney J, Kouttab N, Holme S, Kurtis J, Cheves T and Nelson E. Storage of platelet-rich plasma-derived platelet concentrate pools in plasma and additive solution. Transfusion 2006; 46: 835-40. PubMed  
  5. Dzik WH, Cusack WF, Sherburne B and Kickler T. The effect of prestorage white cell reduction on the function and viability of stored platelet concentrates. Transfusion 1992; 32: 334-9. PubMed  
  6. Fournel JJ, Zingsem J, Riggert J, et al. A multicenter evaluation of the routine use of a new white cell-reduction apheresis system for collection of platelets. Transfusion 1997; 37: 487-92. PubMed  
  7. Burgstaler EA, Pineda AA, Potter BM and Brown R. Plateletapheresis with a next generation blood cell separator. J Clin Apher 1997; 12: 55-62. PubMed  
  8. Heal JM, Singal S, Sardisco E and Mayer T. Bacterial proliferation in platelet concentrates. Transfusion 1986; 26: 388-90. PubMed  
  9. Guidelines for the use of platelet transfusions. Br J Haematol 2003; 122: 10-23. PubMed  
  10. Stanworth SJ, Hyde C, Heddle N, Rebulla P, Brunskill S and Murphy MF. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev, issue 2, 2004. The Cochrane Library  
  11. Strauss RG. Pretransfusion trigger, platelet counts and dose for prophylactic platelet transfusions. Curr Opin Hematol 2005; 12: 499-502. PubMed  
  12. Hiippala S. Replacement of massive blood loss. Vox Sang 1998; 74 (suppl 2): 399-407.
  13. Woodman RC and Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990; 76: 1680-97. Blood  
  14. de la Rubia J, Plume G, Arriaga F, Carpio N, Sanz MA and Marty ML. Platelet transfusion and thrombotic thrombocytopenic purpura. Transfusion 2002; 42: 1384-5. PubMed  
  15. Carr JM, Kruskall MS, Kaye JA and Robinson SH. Efficacy of platelet transfusions in immune thrombocytopenia. Am J Med 1986; 80: 1051-4. PubMed  
  16. Stanworth SJ, Hyde C, Brunskill S and Murphy MF. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now? Br J Haematol 2005; 131: 588-95. PubMed  
  17. Strauss RG. Low-dose prophylactic platelet transfusions: time for further study, but too early for routine clinical practice. Transfusion 2004; 44: 1680-2. PubMed  
  18. Heddle NM, Cook RJ, Sigouin C, Slichter SJ, Murphy M and Rebulla P. A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia. Transfusion 2006; 46: 903-11. PubMed  
  19. O'Connell B, Lee EJ and Schiffer CA. The value of 10-minute posttransfusion platelet counts. Transfusion 1988; 281: 66-7. PubMed  
  20. Legler TJ, Fischer I, Dittmann J, et al. Frequency and causes of refractoriness in multiply transfused patients. Ann Hematol 1997; 74: 185-9. PubMed  
  21. Lee EJ and Schiffer CA. ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial. Transfusion 1989; 29: 384-9. PubMed  
  22. Leucocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997; 337: 1861-9. New England Journal of Medicine  
  23. Duquesnoy RJ, Filip DJ, Rodey GE, Rimm AA and Aster RH. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients. Am J Hematol 1977; 2: 219-26. PubMed  
  24. Rebulla P, Morelati F, Revelli N, et al. Outcomes of an automated procedure for the selection of effective platelets for patients refractory to random donors based on cross-matching locally available platelet products. Br J Haematol 2004; 125: 83-9. PubMed  
  25. Porretti L, Marangoni F, Rebulla P and Sirchia G. Frozen platelet plates for platelet antibody detection and cross-match. Vox Sang 1994; 67: 52-7. PubMed  
  26. Brecher ME and Hay SN. Bacterial contamination of blood components. Clin Microbiol Rev 2005; 18: 195-204. PubMed  
  27. Lin L, Cook DN, Wiesehahn GP, et al. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 1997; 37: 423-35. PubMed  
  28. Lichtiger B and Hester JP. Transfusion of Rh-incompatible blood components to cancer patients. Haematologia (Budap) 1986; 19: 81-8. PubMed  
  29. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force Transfus Med 1996; 6: 261-71. PubMed  
  30. Anderson KC and Weinstein HJ. Transfusion-associated graft-versus-host disease. N Engl J Med 1990; 323: 315-21. New England Journal of Medicine  
  31. Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005; 33: 721-6. PubMed  
  32. Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J and Blajchman MA. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 2005; 19: 2-31. PubMed  
  33. Silliman CC and McLaughlin NJ. Transfusion-related acute lung injury. Blood Rev 2006; 20: 139-59. PubMed  
  34. Vassallo RR. Review: IgA anaphylactic transfusion reactions. Part I. Laboratory diagnosis, incidence, and supply of IgA-deficient products. Immunohematol 2004; 20: 226-33. PubMed  
  • Ewa Lassén, överläkare och medicinsk chef, Klinisk Immunologi och Transfusionsmedicin, Laboratoriemedicin, Norrlands universitetssjukhus, Umeå

Tidigare sakkunniga

  • Aurora Espinosa, överläkare, avdelningen för immunologi och transfusionsmedicin, St. Olavs Hospital, Trondheim